Cargando…
Prediction of Rupture by Complete Blood Count in Tubal Ectopic Pregnancies Treated with a Single-Dose Methotrexate Protocol
Objective The availability of reliable and inexpensive markers that can be used to determine the risk of rupture during methotrexate (MTX) treatment in ectopic pregnancies (EPs) is considerable. The aim of the present study is to investigate the role of systemic inflammatory markers such as leukocy...
Autores principales: | Reis, Yıldız Akdaş, Akay, Arife, Diktaş, Elif Gülşah, Özkan, Merve, Öztürk, Neslihan, Özkan, Doğukan, Çakır, Betül Tokgöz, Erkaya, Salim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Revinter Publicações Ltda.
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579924/ https://www.ncbi.nlm.nih.gov/pubmed/37846182 http://dx.doi.org/10.1055/s-0043-1772485 |
Ejemplares similares
-
Is There a Predictable Cost-Benefit Ratio in Preeclampsia?
por: Ozkan, Dogukan, et al.
Publicado: (2023) -
Apoptosis versus necrosis in tubal ectopic pregnancies following Methotrexate
por: Gil, Yaron, et al.
Publicado: (2023) -
Predictors of Successful Medical Management With Methotrexate in Unruptured Tubal Ectopic Pregnancy
por: Ray, Alokananda, et al.
Publicado: (2022) -
Treatment success with two doses of methotrexate vs single dose of methotrexate in Ectopic Tubal Pregnancy
por: Khakwani, Mehnaz, et al.
Publicado: (2022) -
Uterine artery embolization in association with methotrexate infusion for the treatment of tubal ectopic pregnancy
por: Li, Zhi, et al.
Publicado: (2019)